T9G-24893-78983
3 vaccinations
3 coded responses
28 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 446 / OH
- Registered
- 2021-01-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-19
Registered in v-safe
-
2021-01-19
Dose 1 — Moderna
- 2021-01-19
- 2021-01-20
- 2021-01-22
- 2021-01-23
- 2021-01-24
- 2021-01-25
- 2021-01-26
- 2021-02-02
- 2021-02-09
-
2021-02-16
Dose 2 — Moderna
-
2021-02-16
Health check-in — day 0, dose 2Feeling: Good · Site: Pain, Redness · Fatigue or tirednessAdult check-in
-
2021-02-17
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-02-18
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-02-19
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Abdominal painAdult check-in
- 2021-02-20
- 2021-02-21
- 2021-02-22
- 2021-02-23
- 2021-03-02
- 2021-03-09
- 2021-03-16
- 2021-03-23
- 2021-03-30
- 2021-05-19
- 2021-08-17
-
2021-12-18
Dose 3 — Pfizer-BioNTech
-
2022-02-16
Survey response — 12 months, dose 2MedDRA: Pregnancy — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Pregnancy symptomsMedDRA releases: 2024-11 · check-in free text available
-
2022-03-19
Survey response — 3 months, dose 3MedDRA: Nasopharyngitis — Feeling: FairFree text: Head coldMedDRA releases: 2024-11 · check-in free text available
- 2022-06-18
-
2022-12-20
Survey response — 12 months, dose 3MedDRA: Anxiety — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: AnxietyMedDRA releases: 2024-11 · check-in free text available
-
2022-12-20
Report sent to call center — 12 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-12-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-19 | Moderna | |
| 2 | 2021-02-16 | Moderna | |
| 3 | 2021-12-18 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 11 — 12 months, dose 2
Symptoms: Pregnancy symptoms
Release 11 — 3 months, dose 3
Symptoms: Head cold
Release 12 — 12 months, dose 3
Symptoms: Anxiety
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Anxiety | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release